Adverse Outcomes Associated With Interleukin-6 in Patients Recently Hospitalized for Heart Failure With Preserved Ejection Fraction
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adverse Outcomes Associated With Interleukin-6 in Patients Recently Hospitalized for Heart Failure With Preserved Ejection Fraction
Authors
Keywords
-
Journal
Circulation-Heart Failure
Volume 16, Issue 4, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2023-03-10
DOI
10.1161/circheartfailure.122.010051
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interleukin-6 and Outcomes in Acute Heart Failure: An ASCEND-HF Sub-Study
- (2021) Antonio L. Perez et al. JOURNAL OF CARDIAC FAILURE
- Inflammatory markers and incident heart failure in older men: the role of NT-proBNP
- (2021) Douglas GJ McKechnie et al. Biomarkers in Medicine
- Interleukin-6 Could Be a Potential Prognostic Factor in Ambulatory Elderly Patients with Stable Heart Failure: Results from a Pilot Study
- (2021) Marina Povar-Echeverría et al. Journal of Clinical Medicine
- Effect of Empagliflozin on Worsening Heart Failure Events in Patients with Heart Failure and a Preserved Ejection Fraction: The EMPEROR-Preserved Trial
- (2021) Milton Packer et al. CIRCULATION
- Comparison of Soluble ST2, Pentraxin-3, Galectin-3, and High-Sensitivity Troponin T of Cardiovascular Outcomes in Patients With Acute Decompensated Heart Failure
- (2021) Masayoshi Yamamoto et al. JOURNAL OF CARDIAC FAILURE
- Interleukin 6 and Development of Heart Failure With Preserved Ejection Fraction in the General Population
- (2021) Yook Chin Chia et al. Journal of the American Heart Association
- Diagnostic and prognostic value of serum C-reactive protein in heart failure with preserved ejection fraction: a systematic review and meta-analysis
- (2020) Ishan Lakhani et al. HEART FAILURE REVIEWS
- Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection Fraction
- (2020) Julio A. Chirinos et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Obese-Inflammatory Phenotypes in Heart Failure With Preserved Ejection Fraction
- (2020) Michael S. Sabbah et al. Circulation-Heart Failure
- Inflammatory Markers and Risk of Heart Failure with Reduced, Mid-Range and Preserved Ejection Fraction
- (2020) Zainab H. Albar et al. JOURNAL OF CARDIAC FAILURE
- Anti-Inflammatory Therapy with Canakinumab for the Prevention of Hospitalization for Heart Failure
- (2019) Brendan M. Everett et al. CIRCULATION
- The clinical significance of interleukin‐6 in heart failure: results from the BIOSTAT‐CHF study
- (2019) George Markousis‐Mavrogenis et al. EUROPEAN JOURNAL OF HEART FAILURE
- OUP accepted manuscript
- (2018) EUROPEAN HEART JOURNAL
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction
- (2017) Jasper Tromp et al. JACC-Heart Failure
- Impact of Race, Ethnicity, and Multimodality Biomarkers on the Incidence of New-Onset Heart Failure With Preserved Ejection Fraction (from the Multi-Ethnic Study of Atherosclerosis)
- (2016) Michael G. Silverman et al. AMERICAN JOURNAL OF CARDIOLOGY
- Deletion of Interleukin-6 Attenuates Pressure Overload-Induced Left Ventricular Hypertrophy and DysfunctionNovelty and Significance
- (2016) Lin Zhao et al. CIRCULATION RESEARCH
- Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial
- (2016) Ola Kleveland et al. EUROPEAN HEART JOURNAL
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN HEART JOURNAL
- Interleukin-6 increases matrix metalloproteinase-14 (MMP-14) levels via down-regulation of p53 to drive cancer progression
- (2016) Jillian M. Cathcart et al. Oncotarget
- Plasma kidney injury molecule-1 in heart failure: renal mechanisms and clinical outcome
- (2015) Johanna E. Emmens et al. EUROPEAN JOURNAL OF HEART FAILURE
- Galectin-3 in Heart Failure With Preserved Ejection Fraction
- (2015) Omar F. AbouEzzeddine et al. JACC-Heart Failure
- Galectin-3 in patients with heart failure with preserved ejection fraction: results from the Aldo-DHF trial
- (2014) Frank Edelmann et al. EUROPEAN JOURNAL OF HEART FAILURE
- Reference range and short- and long-term biological variation of interleukin (IL)-6, IL-17A and tissue necrosis factor-alpha using high sensitivity assays
- (2013) John Todd et al. CYTOKINE
- A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
- (2013) Walter J. Paulus et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Profile of microvolt T-wave alternans testing in 1003 patients hospitalized with heart failure
- (2012) Colette E. Jackson et al. EUROPEAN JOURNAL OF HEART FAILURE
- Interleukin-6 stimulates epithelial sodium channels in mouse cortical collecting duct cells
- (2010) Ke Li et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Antibody against interleukin-6 receptor attenuates left ventricular remodelling after myocardial infarction in mice
- (2010) M. Kobara et al. CARDIOVASCULAR RESEARCH
- Inflammatory Markers and Incident Heart Failure Risk in Older Adults
- (2010) Andreas Kalogeropoulos et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Association of Urinary Inflammatory Markers and Renal Decline in Microalbuminuric Type 1 Diabetics
- (2008) P. P. Wolkow et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now